首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9013篇
  免费   768篇
  国内免费   306篇
耳鼻咽喉   31篇
儿科学   101篇
妇产科学   69篇
基础医学   408篇
口腔科学   139篇
临床医学   648篇
内科学   806篇
皮肤病学   153篇
神经病学   396篇
特种医学   230篇
外科学   484篇
综合类   1144篇
一般理论   3篇
预防医学   1506篇
眼科学   285篇
药学   2174篇
  12篇
中国医学   1367篇
肿瘤学   131篇
  2024年   19篇
  2023年   230篇
  2022年   294篇
  2021年   453篇
  2020年   478篇
  2019年   449篇
  2018年   406篇
  2017年   397篇
  2016年   268篇
  2015年   254篇
  2014年   769篇
  2013年   622篇
  2012年   708篇
  2011年   764篇
  2010年   548篇
  2009年   445篇
  2008年   472篇
  2007年   471篇
  2006年   347篇
  2005年   254篇
  2004年   234篇
  2003年   206篇
  2002年   145篇
  2001年   106篇
  2000年   101篇
  1999年   76篇
  1998年   57篇
  1997年   57篇
  1996年   43篇
  1995年   42篇
  1994年   50篇
  1993年   34篇
  1992年   33篇
  1991年   33篇
  1990年   24篇
  1989年   11篇
  1988年   17篇
  1987年   12篇
  1986年   16篇
  1985年   37篇
  1984年   23篇
  1983年   14篇
  1982年   18篇
  1981年   15篇
  1980年   7篇
  1979年   7篇
  1977年   4篇
  1976年   3篇
  1975年   6篇
  1974年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 建立细叶亚菊的质量标准,为其质量控制和合理开发利用提供科学参考。方法 采用性状鉴别、显微鉴别、薄层色谱法(TLC)对细叶亚菊进行定性分析;参照《中国药典》(2020年版)通则方法对细叶亚菊水分、总灰分、酸不溶性灰分、水溶性浸出物进行含量检查;利用高效液相色谱法(HPLC)测定细叶亚菊中绿原酸、异绿原酸A的含量。结果 确定了细叶亚菊的药材性状及显微特征。TLC鉴别显示,供试品(细叶亚菊药材)与对照品(绿原酸、异绿原酸A)在相应位置上均显示相同颜色的荧光斑点。13批细叶亚菊水分、总灰分、酸不溶性灰分、浸出物的含量分别为8.55%-13.07%、6.81%-12.68%、1.11%-3.53%、8.41%-11.64%;绿原酸、异绿原酸A的含量范围分别为0.072%-0.440%、0.283%-1.324%(n=3)。结论 本研究建立的方法准确稳定,可为细叶亚菊的质量控制提供参考。暂规定细叶亚菊水分不得过12.0%,总灰分不得过10.0%,酸不溶性灰分不得过2.5%,水溶性浸出物不得少于8.0%,绿原酸不得少于0.2%,异绿原酸A不得少于0.6%。  相似文献   
2.
PurposeTo assess the safety and tolerability of a vandetanib-eluting radiopaque embolic (BTG-002814) for transarterial chemoembolization (TACE) in patients with resectable liver malignancies.Materials and MethodsThe VEROnA clinical trial was a first-in-human, phase 0, single-arm, window-of-opportunity study. Eligible patients were aged ≥18 years and had resectable hepatocellular carcinoma (HCC) (Child-Pugh A) or metastatic colorectal cancer (mCRC). Patients received 1 mL of BTG-002814 transarterially (containing 100 mg of vandetanib) 7–21 days prior to surgery. The primary objectives were to establish the safety and tolerability of BTG-002814 and determine the concentrations of vandetanib and the N-desmethyl vandetanib metabolite in the plasma and resected liver after treatment. Biomarker studies included circulating proangiogenic factors, perfusion computed tomography, and dynamic contrast-enhanced magnetic resonance imaging.ResultsEight patients were enrolled: 2 with HCC and 6 with mCRC. There was 1 grade 3 adverse event (AE) before surgery and 18 after surgery; 6 AEs were deemed to be related to BTG-002814. Surgical resection was not delayed. Vandetanib was present in the plasma of all patients 12 days after treatment, with a mean maximum concentration of 24.3 ng/mL (standard deviation ± 13.94 ng/mL), and in resected liver tissue up to 32 days after treatment (441–404,000 ng/g). The median percentage of tumor necrosis was 92.5% (range, 5%–100%). There were no significant changes in perfusion imaging parameters after TACE.ConclusionsBTG-002814 has an acceptable safety profile in patients before surgery. The presence of vandetanib in the tumor specimens up to 32 days after treatment suggests sustained anticancer activity, while the low vandetanib levels in the plasma suggest minimal release into the systemic circulation. Further evaluation of this TACE combination is warranted in dose-finding and efficacy studies.  相似文献   
3.
4.
PurposeTo compare the characteristics of polidocanol (POL) and ethanolamine oleate (EO) sclerosing foams produced by a Shirasu porous glass membrane (SPGM) device with those made using a 3-way stopcock (3WSC).Materials and MethodsFoam half-life times were measured in an ex-vivo benchtop study. Computed tomography (CT) images of each foam were obtained over the time course, and a CT texture analysis was conducted. The bubble size in each foam was measured by an optical microscope.ResultsMedian foam half-life times were longer in the SPGM group than in the 3WSC group (POL: 198 vs 166 s, P = .02; EO: 640 vs 391 s, P < .01). In the CT texture analysis, median standard deviation (SD) and entropy (randomness) were lower, and median energy (uniformity) and gray-level cooccurrence matrix (GLCM) homogeneity were higher in the SPGM group than in the 3WSC group (POL SD: at 30 s and 50–300 s; POL entropy: at 0–60 s; EO SD: at 0–600 s; EO entropy: at 0–460 s; POL energy: at 0–40 s; POL GLCM homogeneity: at 0–250 s; EO energy: at 0–360 s; EO GLCM homogeneity: at 0–480 s; all P < .05). Median bubble diameters in the SPGM group and in the 3WSC group were 69 and 83 μm (P < .01), respectively, in the POL foam; and 36 and 36 μm (P = .45), respectively, in the EO foam.ConclusionsPOL and EO foams had greater uniformity and longer foam half-life time when prepared with an SPGM device than with a 3WSC.  相似文献   
5.
6.
Analytical procedure for detection and quantification of etaqualone in human blood and urine using GC–MS/MS was established and applied to authentic human samples obtained from volunteers. A liquid–liquid extraction method was employed. Each 1.0 mL of blood or urine was alkalized and extracted with diethyl ether. The solvent layer was evaporated to dryness and reconstituted with methanol then analyzed by GC–MS/MS. linear relationships within the concentration range of 1–100 ng/mL were obtained in calibrators for both blood and urine, demonstrating correlation coefficients values being>0.999. For blood and urine samples, the intra-day assay precision and accuracy values are each less than 3.65%, 7.13%, and 6.02%, 9.12%; those values of the inter-day assay are each less than 1.82%, 6.74%, and 3.99%, 7.41%. The extraction recovery rates for etaqualone ranged from 98.7% to 106%. The lower limit of quantifications was 1.0 ng/mL in both blood and urine. Stabilities of etaqualone in blood and urine were satisfactory under various temperatures within 15 days. 8.51 and 2.06 ng/mL of etaqualone in blood and urine were detected at 4 h later oral ingestion; 6.91 and 3.94 ng/mL of etaqualone were also detected 30 min and 2 h later smoking from blood and urine.  相似文献   
7.
8.
What is important to think about in surgical education and technical skills training? Technical skills training is grounded in social cognitive theory and the concepts of modeling and self-efficacy. Cognitive and nontechnical learning is critical to supplement the overall proficiency of the surgical learner in performing an operation. Technical learning is cemented by deliberate practice and there is benefit to productive struggle and failure. External cognitive load should be minimized to maximized operative skills advancement.  相似文献   
9.
姚奕  许浚  黄广欣  张铁军  刘昌孝 《中草药》2020,51(10):2661-2670
香薷作为常用解表中药,其化学成分多样,临床应用十分广泛。对香薷进行本草考证、化学成分和主要药理活性总结,并在此基础上结合质量标志物(Q-marker)的核心概念,从生源途径、传统药性药效、药动学和体内过程以及可测成分等方面对香薷Q-marker进行预测分析,为其质量评价提供了理论依据。  相似文献   
10.
目的:研究制定知母种子的质量分级标准。方法:通过对不同产地20个批次知母种子的净度、千粒质量、含水量、生活力、发芽率等指标测定和外观形态观察,利用Excel 2010、SPSS 20.0软件对以上数据进行相关分析、主成分以及K-均值聚类分析,初步确定知母种子质量分级指标和分级标准,且以各等级知母种子分别在田间对比种植,通过测定1年产苗量,2年药材产量及有效成分含量,验证知母种子质量分级标准的合理性。结果:Ⅰ级知母种子发芽率不低于85%,千粒质量不低于7.5 g,净度不低于95%;Ⅱ级知母种子发芽率不低于70%,千粒质量不低于7.0 g,净度不低于85%;Ⅲ级知母种子发芽率不低于65%,千粒质量不低于6.0 g,净度不低于80%;各级种子含水量均小于10%。结论:发芽率和千粒质量为知母种子质量分级标准的主要指标,净度和含水量为参考指标。不同等级知母种子种植后对知母种苗产量、药材产量及质量会有显著影响。该研究制定的知母种子质量分级标准科学可行、符合生产实际,为知母的种子质量评价和规范化栽培提供参考依据。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号